Medicare Enrolled

Dr. Srinivas Yallapragada

Interventional Cardiology · Dallas, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
8440 WALNUT HILL LN STE 700, Dallas, TX 75231
2143613300
In practice since 2009 (16 years)
NPI: 1174752372 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Yallapragada from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yallapragada? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Yallapragada

Dr. Srinivas Yallapragada is an interventional cardiology specialist in Dallas, TX, with 16 years of NPI registration. Based on federal Medicare data, Dr. Yallapragada performed 1,909 Medicare services across 1,460 unique beneficiaries.

Between the years covered by Open Payments, Dr. Yallapragada received a total of $85,655 from 47 pharmaceutical and/or device companies across 586 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Yallapragada is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ 1,909 Medicare services $85,655 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,909
Medicare services
Bottom 45% in TX for interventional cardiology
1,460
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~119 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity 395 $62 $141
Office visit, established patient (30-39 min) 250 $95 $206
Electrocardiogram (EKG), 12-lead 200 $10 $60
Echocardiogram, transthoracic 145 $52 $205
Office visit, established patient (20-29 min) 124 $55 $139
Initial hospital admission, high complexity 114 $135 $393
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes 105 $10 $39
Hospital follow-up visit, high complexity 70 $94 $202
New patient office visit (45-59 min) 57 $123 $320
Nuclear medicine studies of heart muscle at rest and with stress and spect 39 $58 $236
Ultrasound of heart with color-depicted blood flow, rate and valve function 38 $2 $27
Ultrasound of heart, follow-up 37 $18 $91
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician 36 $10 $47
Heart muscle strain imaging 35 $8 $38
Cardiac catheterization 31 $177 $1,124
Ultrasound of heart blood flow, valves and chambers, follow-up 30 $5 $35
Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel 28 $54 $235
Ultrasound of both sides of head and neck blood flow 27 $29 $92
Coronary stent placement 22 $402 $1,804
Ultrasound of heart with probe in esophagus, with report 22 $84 $392
Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist 22 $233 $1,346
Initial hospital admission, moderate complexity 22 $87 $268
Ultrasound evaluation of blood vessel with review by radiologist, initial vessel 20 $64 $293
Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel 16 $72 $731
Review by radiologist of abdominal aorta image 13 $52 $285
Replacement of aortic valve through the skin and femoral artery 11 $570 $4,038
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
14.5% high complexity
13.6% medium
71.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$85,655
Total received (2018-2024)
Avg $12,236/year across 7 years
Top 7% in TX for interventional cardiology
47
Companies
586
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$61,819 (72.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,836 (27.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$20,293
2023
$31,370
2022
$4,691
2021
$13,868
2020
$1,929
2019
$8,825
2018
$4,679

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Inari Medical, Inc.
$44,362
Penumbra, Inc.
$12,434
Medtronic, Inc.
$5,295
BARD PERIPHERAL VASCULAR, INC.
$4,877
ABIOMED
$3,415
Abbott Laboratories
$3,263
Bard Peripheral Vascular, Inc.
$2,218
Cardiovascular Systems Inc.
$1,575
Medical Device Business Services, Inc.
$1,350
Boston Scientific Corporation
$859
EKOS Corporation
$803
Novartis Pharmaceuticals Corporation
$802
Avinger Inc.
$616
Edwards Lifesciences Corporation
$451
Amgen Inc.
$402
PFIZER INC.
$361
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$280
AstraZeneca Pharmaceuticals LP
$223
Imperative Care, Inc
$208
HEARTFLOW, INC.
$188
Merck Sharp & Dohme LLC
$180
Medtronic Vascular, Inc.
$175
Shockwave Medical, Inc
$151
Philips Electronics North America Corporation
$136
Janssen Pharmaceuticals, Inc
$118
E.R. Squibb & Sons, L.L.C.
$117
BIOTRONIK INC.
$104
Amarin Pharma Inc.
$84
Boehringer Ingelheim Pharmaceuticals, Inc.
$70
Terumo Medical Corporation
$50
SCPHARMACEUTICALS INC.
$50
Reflow Medical Inc
$49
AtriCure, Inc.
$47
HeartFlow, Inc.
$46
CVRx, Inc.
$45
BTG International, Inc.
$45
Itamar Medical Inc
$33
Kiniksa Pharmaceuticals, Ltd.
$28
Endologix LLC
$25
ShockWave Medical, Inc
$22
Vital Connect, Inc
$18
Recor Medical Inc
$17
Kiniksa Pharmaceuticals International, plc
$15
Teleflex LLC
$13
Gilead Sciences, Inc.
$13
SANOFI-AVENTIS U.S. LLC
$12
Cardinal Health 200, LLC
$11
Top 3 companies account for 72.5% of total payments
Associated products mentioned in payments ›
ABRE · AMPLATZER · ANGIO-SEAL · Acculink carotid stent system · Arcalyst · Asahi Fielder coronary guide wire · Assurity Pacemaker · BRILINTA · Barostim Neo System · CAMZYOS · CONFIRM RX · COREVALVE EVOLUT R · CT THROMBECTOMY SYSTEM KIT · Carto 3 System · Claria MRI · ClosureFast · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · DIAMONDBACK CORONARY · DIAMONDBACK PERIPHERAL · Diamondback Coronary · EKOSONIC · ELIQUIS · ENDOCROSS Device · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · ESPRIT · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Emboshield NAV6 system · FARXIGA · FFRct · FLOWTRIEVER CATHETER · FUROSCIX · GENERAL THERAPIES · GENERAL THERAPIES · HAWKONE · HEARTRAIL · IGT D Therapy · Impella · Indigo · Indigo System · JARDIANCE · LEQVIO · LIFESTREAM · LUTONIX · LUTONIX Drug Coated Balloon · LUX-Dx Insertable Cardiac Monitor · LifeVest · Lutonix Drug Coated Balloon · MANTA · MICRA · MITRACLIP · MynxGrip Vascular Closure Device · PANTHERIS · PARADISE RENAL DENERVATION SYSTEM · PERCLOSE PROGLIDE · PORTICO · PRALUENT · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · PressureWire FFR · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · ROTABLATOR · Repatha · Reveal LINQ · S · SAPIEN 3 Ultra RESILIA · SYMPHONY CATHETER · SYNERGY · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Supera peripheral stent system · Turbo-Power · VENASEAL · VENOVO · VERQUVO · VYNDAQEL · Vascepa · Vascular Lithotripsy · Venovo · WatchPATONE · XARELTO · XIENCE SKYPOINT · Xience Alpine cornary stent system · Xience Sierra Coronary Stent System · Xience cornary stent systems
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (72%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in interventional cardiology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for interventional cardiology in TX.

Equivalent to $4,487 per 100 Medicare services performed
Looking for an interventional cardiology specialist in Dallas?
Compare interventional cardiologists in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse interventional cardiologists nearby

Geographic Context

Interventional cardiologists within 10 mi
48
Per 100K population
1.8
County median income
$74,149
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Yallapragada is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 7% of TX peers, with 16 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Yallapragada experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Yallapragada performed 395 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yallapragada receive payments from pharmaceutical companies?
Yes. Dr. Yallapragada received a total of $85,655 from 47 companies across 586 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yallapragada's costs compare to other interventional cardiologists in Dallas?
Dr. Yallapragada's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yallapragada) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →